Welcome

By selecting the Yes, leave Opcaseportalsg.com option you understand that you are leaving the website and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third-party sites, you understand that you do so at your own risk.

The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If you reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.

Yes, opcaseportalsg.com Cancel

Acknowledgements

The clinical cases included in the Osteoporosis Case Binder were provided by the following experts:

Acknowledgements

black pen

Acknowledgements

Dato’ Dr. Joon-Kiong Lee DSPN, DJN

President, Malaysian Bone Health Optimization Network (MyBONe).
Past President, Fragility Fracture Network Malaysia (FFNM).
Deputy Medical Director and Consultant Orthopedic Surgeon

Beacon Hospital, Petaling Jaya, Malaysia.

#Tag7
Read More
white pen

Acknowledgements

Prof. Datuk Dr. Sabarul Afian Mokhtar

Senior Consultant Orthopaedic Surgeon

Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan
Malaysia (HCTM UKM)

#Tag7
Read More
CTA / SHOW ALL OF Acknowledgements
  • Important Safety Information:
    Osteoporosis Case Binder
    This curated collection of patient case studies aims to provide healthcare practitioners in the area of bone health, with a comprehensive understanding of risk-based treatment approach in the long-term management of patients living with osteoporosis.
    The patient cases were contributed by bone health experts from respective clinical setting, incorporating evidence-based discussions, guidelines and clinical considerations in the individualised treatment sequencing plans of different real-world scenarios..
    Please review full product information before prescribing
    For Healthcare Professionals Only.
    Please refer to full prescribing information prior to administration
    For information on Amgen products or to report an adverse event involving an Amgen product, please contact Medical Information at 800-616-7094 or medinfo.JAPAC@amgen.com
    SC-SGP-CP-00137-0525